This clinical trial is focused on patients who are at risk for complications after undergoing non-cardiac surgeries, such as general or urology surgeries. The study is investigating the use of a treatment involving the administration of oxygen through a nasal cannula at a rate of 3 liters per minute. The aim is to see if this oxygen supply can help reduce temporary drops in blood oxygen levels, known as desaturation, which can occur after surgery.
The trial is called the AIOLOS trial and will compare two groups of patients. One group will receive the oxygen treatment, while the other group will receive the standard care that is typically provided after surgery. The main goal is to observe the average time that patients’ blood oxygen levels fall below 90% during the first two days after their surgery. This will be measured using a device called a pulse oximeter, which is a simple tool that clips onto a finger to monitor oxygen levels in the blood.
In addition to monitoring oxygen levels, the study will also look at other factors such as the quality of recovery on the first day after surgery, the occurrence of delirium, and any surgical site infections within 30 days. The trial is expected to start recruiting participants in October 2024 and aims to conclude by November 2025. The results of this study could help improve care for patients recovering from surgery by providing insights into the benefits of supplemental oxygen therapy.



Austria